Does Humana Cover Weight Loss Treatment in New Mexico? A 2026 Guide

Last updated: July 13, 2026

If you have Humana coverage in New Mexico and are looking into weight loss treatment, the most important thing to understand in 2026 is that Humana operates exclusively as a Medicare Advantage (MA) insurer in New Mexico. Humana exited the commercial insurance market in 2024. This means all weight loss coverage information on this page applies to Medicare Advantage plan members only — including the landmark Medicare GLP-1 Bridge program that launched July 1, 2026.

Wondering if your Humana Medicare Advantage plan may cover weight loss treatment in New Mexico? Explore weight loss treatment options at Klarity Health — 2,000+ licensed providers.

The 2026 Medicare GLP-1 Bridge: $50/Month Wegovy, Zepbound, and Foundayo for Eligible Members

Effective July 1, 2026, the Centers for Medicare & Medicaid Services (CMS) launched the Medicare GLP-1 Bridge program, which represents the most significant change to weight loss medication access for Medicare Advantage members in decades. Under this program, eligible Medicare Advantage and Part D (MAPD) members may access Wegovy (semaglutide), Zepbound (tirzepatide), and the newly approved Foundayo at a fixed $50-per-month cost-sharing amount — regardless of their plan’s standard Part D formulary placement for these medications.

This is a critical distinction: the Medicare GLP-1 Bridge is a CMS-administered benefit that operates outside the standard Humana Pharmacy Solutions (HPS) Part D formulary. Humana’s standard Part D formulary has historically excluded weight loss medications (consistent with the long-standing Medicare Part D statutory exclusion for weight loss drugs). The CMS GLP-1 Bridge bypasses that exclusion for qualifying members.

Medicare GLP-1 Bridge — Key Details

• Launch date: July 1, 2026
• Covered medications: Wegovy (semaglutide), Zepbound (tirzepatide), Foundayo
• Member cost-sharing: $50 per month (fixed, regardless of plan tier)
• Who administers it: CMS — this is a federal benefit, not a Humana plan benefit
• Eligible plans: Medicare Advantage and Part D plans (MAPD) — must be enrolled in a qualifying Humana MAPD plan
• BMI requirement: Members typically must have a BMI of 30 or higher, or 27 or higher with an obesity-related comorbidity (e.g., hypertension, type 2 diabetes, obstructive sleep apnea)
• How to access: Ask your provider about Medicare GLP-1 Bridge eligibility; contact Humana at 1-800-448-6262 or CMS at 1-800-633-4227 to confirm your specific plan’s enrollment in the program

Important: D-SNP (Dual Eligible Special Needs Plan) members — those enrolled in both Medicare and Medicaid — may have different cost-sharing structures. Contact Humana directly to verify GLP-1 Bridge access and cost-sharing for your specific D-SNP plan variant.

Humana in New Mexico: Medicare Advantage Only

Humana fully exited the commercial (employer-sponsored and individual marketplace) health insurance market in 2024. As of 2026, Humana offers coverage in New Mexico exclusively through Medicare Advantage plans, which include:

• Gold Plus HMO plans
• HumanaChoice PPO plans
• Regional/local HMO-POS plans
• Dual Eligible Special Needs Plans (D-SNPs)

If you are under 65 and seeking commercial weight loss coverage in New Mexico, Humana is not a current market option. For commercially insured patients, refer to our guides for UnitedHealthcare, Presbyterian Health Plan, Aetna, or Cigna in New Mexico.

HPS Part D Weight Loss Formulary (Standard Coverage Context)

Outside of the Medicare GLP-1 Bridge program, the standard Humana Pharmacy Solutions (HPS) Part D formulary for weight loss medications reflects longstanding Medicare Part D exclusions. The following is the typical coverage structure for HPS plans in 2026, though members should always verify their specific plan’s current formulary:

Coverage varies by individual plan. Always verify current formulary status at humana.com/pharmacytools or by calling HPS at 1-800-379-0092.

Prior Authorization (PA) Criteria for Weight Loss Medications

For weight loss medications accessed through the Medicare GLP-1 Bridge or through any HPS formulary pathway, prior authorization typically requires documentation of:

• BMI of 30 or higher (obesity); or
• BMI of 27 or higher with at least one weight-related comorbidity such as type 2 diabetes, hypertension, dyslipidemia, or obstructive sleep apnea
• Documentation of prior dietary and lifestyle intervention efforts
• Absence of contraindications (e.g., personal or family history of medullary thyroid carcinoma for GLP-1 medications)

PA decisions are typically rendered within 72 hours for standard requests and 24 hours for urgent cases. If your PA request is denied, you have the right to request an internal review through Humana and then an Independent Review Entity (IRE) appeal if the denial is upheld. Contact Humana’s member services at 1-800-448-6262 to initiate an appeal.

EPCS and Controlled Substance Note

Electronic Prescribing of Controlled Substances (EPCS) regulations under 21 CFR Part 1311 apply only to Schedule II controlled substances. All primary weight loss medications prescribed through Klarity Health’s telehealth platform are non-scheduled or Schedule IV — none require EPCS under the Schedule II threshold:

• GLP-1 medications (Wegovy, Zepbound, Foundayo, Saxenda): Non-scheduled — no DEA scheduling
• Contrave (naltrexone/bupropion): Non-scheduled — neither component is a controlled substance in combination form
• Orlistat: Non-scheduled
• Phentermine, Qsymia: Schedule IV — not Schedule II; EPCS requirement under § 456.44 does not apply, though some prescribers may voluntarily use secure electronic prescribing workflows for all controlled substances

This means telehealth weight loss prescriptions from Klarity Health providers may be issued through standard electronic prescribing without EPCS requirements for any of the above medications.

Parity Law and Weight Loss Coverage Scope

It is important to note that the New Mexico Mental Health Parity law — NMSA 1978 § 59A-23E-19 et seq. — applies specifically to mental health and substance use disorder benefits. It does not extend parity protections to weight loss or obesity treatment coverage.

Weight loss treatment coverage for Humana Medicare Advantage members is governed by:

• The Affordable Care Act (ACA) Essential Health Benefits (EHB) framework
• CMS 42 CFR Part 422, which establishes the federal Medicare Advantage parity framework
• CMS Part D formulary regulations and the GLP-1 Bridge program rules

The NMSA 1978 § 59A-23E-19 state statute governs commercial insurance plans regulated by the New Mexico Office of Superintendent of Insurance (OSI) — it does not apply to Medicare Advantage plans, which are federally regulated by CMS.

Telehealth Weight Loss Treatment with Klarity Health

Klarity Health’s network of 2,000+ licensed providers includes clinicians who specialize in medical weight loss and can prescribe FDA-approved weight loss medications including GLP-1 receptor agonists. Telehealth consultations may be covered under your Humana Medicare Advantage plan’s telehealth or outpatient benefits.

Plan type matters for telehealth access:

• Gold Plus HMO members: Typically require a PCP referral before accessing specialist or telehealth weight loss services. Contact your primary care provider before scheduling a Klarity Health visit to confirm referral requirements under your plan.
• HumanaChoice PPO members: Generally have direct access to telehealth providers without a prior referral, subject to in-network versus out-of-network cost-sharing differences.

Telehealth coverage for obesity treatment — including evaluation, management, and medication prescribing — may be available under the preventive or chronic care benefits of your Humana MA plan. Contact Humana at 1-800-448-6262 to confirm telehealth benefit details for weight management under your specific plan.

Speak with a licensed provider about weight loss treatment options — see if you may qualify.

Important Note for Dual Eligible (D-SNP) Members

If you are enrolled in a Humana Dual Eligible Special Needs Plan (D-SNP) — meaning you have both Medicare and Medicaid coverage — your formulary, cost-sharing, and benefit structure may differ from standard Humana MAPD plans. D-SNP plans coordinate Medicare and Medicaid benefits and may have additional weight loss coverage provisions or different cost-sharing levels for weight loss medications.

When calling Humana or HPS, identify yourself as a D-SNP member to ensure you receive formulary and benefit information specific to your plan. Standard MAPD formulary information may not accurately reflect your D-SNP coverage.

This guide does not provide Medicaid coverage guidance. For Medicaid weight loss coverage in New Mexico, contact the New Mexico Human Services Department (HSD) directly.

Contact Information

• Humana Member Services: 1-800-448-6262 (TTY: 711)
• Humana Pharmacy Solutions (HPS): 1-800-379-0092
• CMS Medicare Hotline (GLP-1 Bridge inquiries): 1-800-633-4227 (1-800-MEDICARE)
• New Mexico Office of Superintendent of Insurance (OSI): 1-855-427-5674 (commercial plans only; CMS governs MA disputes)

Frequently Asked Questions

Does Humana Medicare Advantage cover weight loss medications in New Mexico in 2026?

Humana Medicare Advantage members in New Mexico may access Wegovy, Zepbound, and Foundayo through the Medicare GLP-1 Bridge program launched July 1, 2026, at a $50-per-month cost-sharing amount administered by CMS. This benefit operates outside the standard HPS Part D formulary, which has historically excluded weight loss drugs. Coverage eligibility typically requires a BMI of 30 or higher, or 27 or higher with an obesity-related comorbidity. Always verify your specific plan’s participation in the GLP-1 Bridge program by calling Humana at 1-800-448-6262 or CMS at 1-800-633-4227.

What is the Medicare GLP-1 Bridge and how do I access it through my Humana plan?

The Medicare GLP-1 Bridge is a CMS program effective July 1, 2026, that allows qualifying MAPD members to access Wegovy, Zepbound, and Foundayo at $50 per month — bypassing the standard Part D formulary exclusion for weight loss drugs. To access it, ask your provider to prescribe an eligible GLP-1 medication and confirm with Humana that your plan participates in the CMS GLP-1 Bridge program. Your provider or Klarity Health’s clinical team can help initiate the process and document the required BMI and comorbidity criteria for eligibility.

Does Humana cover phentermine or Qsymia under Medicare in New Mexico?

Phentermine and Qsymia (phentermine/topiramate) are Schedule IV controlled substances available for short-term weight management. Medicare Part D coverage for these medications is limited and varies by plan. Under the standard HPS Part D formulary, phentermine may be available at Tier 1–2 with quantity limits if covered; Qsymia may require prior authorization and REMS compliance. Verify current formulary status for your specific plan with HPS at 1-800-379-0092. EPCS regulations under 21 CFR Part 1311 (Schedule II only) do not apply to these Schedule IV medications.

Does the New Mexico mental health parity law apply to weight loss coverage under my Humana plan?

No. The New Mexico Mental Health Parity Act (NMSA 1978 § 59A-23E-19 et seq.) applies to mental health and substance use disorder benefits under commercial insurance plans regulated by the NM OSI. It does not extend parity protections to weight loss or obesity treatment. Weight loss coverage for Humana Medicare Advantage members is governed by the ACA EHB framework and CMS 42 CFR Part 422, which are federal regulations administered by CMS — not the NM OSI or state parity statute.

Can I see a telehealth provider through Klarity Health for weight loss under my Humana Medicare Advantage plan?

Klarity Health’s 2,000+ licensed providers include clinicians who offer telehealth weight loss consultations and may prescribe FDA-approved weight loss medications including GLP-1 receptor agonists. Whether Klarity Health is covered under your Humana MA plan depends on your plan type and network configuration. Gold Plus HMO members typically need a PCP referral before accessing telehealth weight loss services. HumanaChoice PPO members generally have direct access. Contact Humana at 1-800-448-6262 to confirm telehealth weight management benefits and in-network provider access under your specific plan before scheduling.

Disclaimer: Coverage and formulary information on this page is based on publicly available data as of July 2026 and is intended for general informational purposes only. Insurance coverage varies by individual plan, employer agreement, and annual formulary updates. This page does not constitute insurance advice. Always verify your specific benefits directly with Humana, HPS, or CMS before scheduling treatment or filling a prescription. Klarity Health providers can help you understand your treatment options, but coverage verification is the responsibility of the member and their insurer.

Ready to explore weight loss treatment? Connect with a licensed Klarity Health provider today.